메뉴 건너뛰기
Internal Medicine
Volumn 37, Issue 9, 1998, Pages
Anti-cardiolipin-β2-GPI Complex Antibodies in Idiopathic Thrombocytopenic Purpura
Author keywords

[No Author keywords available]
Indexed keywords

BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; GLYCOPROTEIN;
EID: 0032153485     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.37.796a     Document Type: Article
Times cited : (10)
References (7)
  • 1
    • 0031304683 scopus 로고    scopus 로고
    • Characteristics of the clinical findings in patients with idiopathic thrombocytopenic purpura who are positive for anti-phospholipid antibodies.
    • Funauchi M, Hamada K, Enomoto H, et al. Characteristics of the clinical findings in patients with idiopathic thrombocytopenic purpura who are positive for anti-phospholipid antibodies. Intern Med 36: 882, 1997.
    • (1997) Intern Med , vol.36 , pp. 882
    • Funauchi, M.1    Hamada, K.2    Enomoto, H.3
  • 2
    • 0029832053 scopus 로고    scopus 로고
    • diagnostic and classification criteria for the antiphospholipid/ co factors syndrome: a “mission impossible”?
    • Piette JC. 1996 diagnostic and classification criteria for the antiphospholipid/ co factors syndrome: a “mission impossible”? Lupus 5: 354, 1996.
    • (1996) Lupus , vol.5 , pp. 354
    • Piette, J.C.1
  • 3
    • 84970418044 scopus 로고
    • Disease distribution of p2-glycoprotein I-dependent anticardiolipin antibodies in rheumatic diseases.
    • Kaburaki J, Kuwana M, Yamamoto M, Kawai S, Matsuura E, Ikeda Y. Disease distribution of p2-glycoprotein I-dependent anticardiolipin antibodies in rheumatic diseases. Lupus 4 Suppl 1: S27, 1995.
    • (1995) Lupus , vol.4 , pp. S27
    • Kaburaki, J.1    Kuwana, M.2    Yamamoto, M.3    Kawai, S.4    Matsuura, E.5    Ikeda, Y.6
  • 4
    • 0029585359 scopus 로고
    • Clinical significance of phospholipid-dependent anti-p2-glycoprotein I (P2-GPI) antibodies in systemic lupus erythematosus.
    • Kaburaki J, Kuwana M, Yamamoto M, Kawai S, Matsuura E, Ikeda Y. Clinical significance of phospholipid-dependent anti-p2-glycoprotein I (P2-GPI) antibodies in systemic lupus erythematosus. Lupus 4: 472, 1995.
    • (1995) Lupus , vol.4 , pp. 472
    • Kaburaki, J.1    Kuwana, M.2    Yamamoto, M.3    Kawai, S.4    Matsuura, E.5    Ikeda, Y.6
  • 5
    • 0030078774 scopus 로고    scopus 로고
    • Phospholipid-dependent anti-p2-glycoprotein I (p2-GPI) antibodies and antiphospholipid syndrome.
    • Kaburaki J, Kuwana M, Yamamoto M, Kawai S, Matsuura E, Ikeda Y. Phospholipid-dependent anti-p2-glycoprotein I (p2-GPI) antibodies and antiphospholipid syndrome. Intern Med 35: 105, 1996.
    • (1996) Intern Med , vol.35 , pp. 105
    • Kaburaki, J.1    Kuwana, M.2    Yamamoto, M.3    Kawai, S.4    Matsuura, E.5    Ikeda, Y.6
  • 6
    • 0020436689 scopus 로고
    • The 1982 revised criteria for the classification of systemic lupus erythematosus.
    • Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum25: 1271, 1982.
    • (1982) Arthritis Rheum , vol.25 , pp. 1271
    • Tan, E.M.1    Cohen, A.S.2    Fries, J.F.3
  • 7
    • 0028000905 scopus 로고
    • ‘Primary’, ‘secondary’ and other variants of the antiphospholipid syndrome.
    • Asherson RA, Cervera R. ‘Primary’, ‘secondary’ and other variants of the antiphospholipid syndrome. Lupus 3: 293, 1994.
    • (1994) Lupus , vol.3 , pp. 293
    • Asherson, R.A.1    Cervera, R.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.